Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The residual cardiorenal risk in type 2 diabetes
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 24

Showing 24 citing articles:

Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression
Maria Ida Maiorino, Miriam Longo, Lorenzo Scappaticcio, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 57
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice
Lee‐Ling Lim, Elaine Chow, Juliana C.N. Chan
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 3, pp. 151-163
Closed Access | Times Cited: 53
Finerenone: Questions and Answers—The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist
Luca Di Lullo, Carlo Lavalle, Alessia Scatena, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3992-3992
Open Access | Times Cited: 21
Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)
Jennifer B. Green, Brendan M. Everett, Alokananda Ghosh, et al.
Circulation (2024) Vol. 149, Iss. 13, pp. 993-1003
Closed Access | Times Cited: 6
Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues
Miriam Longo, Lorenzo Scappaticcio, Paolo Cirillo, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 272-272
Open Access | Times Cited: 23
IL-6 and diabetic kidney disease
Lei Zhang, Futian Xu, Liyan Hou
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine
Esther Reijnders, Arnoud van der Laarse, J. Wouter Jukema, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Management of the ‘wicked’ combination of heart failure and chronic kidney disease in the patient with diabetes
David S.H. Bell, Janet B. McGill, Terri Jerkins
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 10, pp. 2795-2804
Open Access | Times Cited: 7
The Impact of Glucagon-like Peptide-1 Receptor Agonists on Kidney Outcomes: A Meta-Analysis of Randomized Placebo-Controlled Trials
Luís Mendonça, H. B. Moura, Paulo Castro‐Chaves, et al.
Clinical Journal of the American Society of Nephrology (2024)
Closed Access | Times Cited: 2
Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease
Chayakrit Krittanawong, Johao Escobar, Hafeez Ul Hassan Virk, et al.
The American Journal of Medicine (2023) Vol. 137, Iss. 3, pp. 202-209
Open Access | Times Cited: 5
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently
Marc Evans, Angharad R. Morgan, Stephen C. Bain, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 5, pp. 889-911
Open Access | Times Cited: 8
Solution is not simple; sodium-glucose cotransporter-2 inhibitor use in Conn syndrome
Utku Erdem Soyaltın
Blood Pressure Monitoring (2024)
Closed Access | Times Cited: 1
Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide
Dario Giugliano, Katherine Esposito, Luca De Nicola
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 4813-4815
Closed Access | Times Cited: 1
Up and down waves of glycemic control and lower-extremity amputation in diabetes
Paola Caruso, Lorenzo Scappaticcio, Maria Ida Maiorino, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Protective effect of ellagic acid against high-glucose-induced injury in human umbilical venous endothelial cells.
Somayeh Sheikh, Hesam Dehghani, Hamid Reza Kazerani
PubMed (2024) Vol. 14, Iss. 1, pp. 138-141
Closed Access
Sodium-Glucose Cotransporter-2 Inhibitors: Who, When & How? Guidance for Use from a Multidisciplinary Practical Approach
Khalifa Abdullah, Magdy ElSharkawy, Emad R. Issak, et al.
International Journal of Clinical Medicine (2024) Vol. 15, Iss. 09, pp. 413-435
Open Access
GLP-1 receptor agonists: new kids in the block of renoprotection for people with type 2 diabetes and chronic kidney disease
Theocharis Koufakis, Djordje S. Popovic, Paschalis Karakasis, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 15, pp. 1979-1982
Closed Access
Semaglutide cuts kidney risk in obesity
Dario Giugliano, Luca De Nicola, Maria Ida Maiorino, et al.
Journal of Endocrinological Investigation (2024) Vol. 48, Iss. 2, pp. 295-298
Closed Access
Deciphering Rho-associated, coiled-coil-containing protein kinase in diabetic nephropathy: small steps towards a giant leap
Keiichiro Matoba
Endocrine Journal (2023) Vol. 70, Iss. 8, pp. 771-776
Open Access | Times Cited: 1
Modern Approaches to Treatment of Chronic Heart Failure in Patients with Type 2 Diabetes Mellitus
Yu. G. Gorb, S. A. Serik, О. В. Ткаченко, et al.
Ukraïnsʹkij žurnal medicini bìologìï ta sportu (2022) Vol. 7, Iss. 1, pp. 14-31
Open Access | Times Cited: 1
Új terápiás stratégiák a diabéteszes vesebetegség kezelésében
Zoltán Balogh
Diabetologia Hungarica (2022) Vol. 30, Iss. 5, pp. 351-358
Open Access | Times Cited: 1
Epidemiology and pathogenesis of cardiorenal syndrome in patients with type 2 diabetes mellitus. (Literature review)
N. A. Pervyshin, S.V. Bulgakova, Р А Галкин, et al.
Russian Journal of Preventive Medicine (2023) Vol. 26, Iss. 8, pp. 107-107
Closed Access
Adropin is involved in the protective effect of ellagic acid against high-glucose induced injury in human umbilical venous endothelial Cells
Somayeh Sheikh, Hesam Dehghani, Hamid Reza Kazerani
Research Square (Research Square) (2022)
Open Access
Renal and metabolic effects of SGLT-2i and DPP-4i according to basal estimated glomerular filtration rate: Analysis from GIOIA, an observational prospective study
Miriam Longo, Lorenzo Scappaticcio, Maria Ida Maiorino, et al.
Diabetes Research and Clinical Practice (2021) Vol. 178, pp. 108990-108990
Closed Access
Page 1

Scroll to top